CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 775789 | 918957 | 84.4% | |
CKD 4 | 2008 | 1003111 | 1194514 | 84.0% | |
CKD 5 | 2009 | 190141 | 217059 | 87.6% | |
CKD 5 | 2010 | 100268 | 109349 | 91.7% | |
CKD 5 | 2011 | 112472 | 124551 | 90.3% | |
CKD 5 | 2012 | 127712 | 142824 | 89.4% | |
CKD 5 | 2013 | 135662 | 152045 | 89.2% | |
CKD003NI | 2014 | 137338 | 151066 | 90.9% | |
CKD003 | 2015 | 129533 | 141708 | 91.4% | |
CKD003 | 2016 | 107036 | 140482 | 76.2% | |
CKD003 | 2017 | 86743 | 119235 | 72.7% | |
CKD003 | 2018 | 85768 | 120315 | 71.3% | |
CKD003 | 2019 | 64733 | 94949 | 68.2% | |
CKD003 | 2020 | 76283 | 113079 | 67.5% | |
CKD003 | 2022 | 73365 | 107426 | 68.3% | |
CKD003 | 2023 | 52133 | 73598 | 70.8% |